A detailed history of Headlands Technologies LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Headlands Technologies LLC holds 766 shares of PTCT stock, worth $30,050. This represents 0.0% of its overall portfolio holdings.

Number of Shares
766
Previous 6,611 88.41%
Holding current value
$30,050
Previous $202,000 86.14%
% of portfolio
0.0%
Previous 0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$30.39 - $37.66 $177,629 - $220,122
-5,845 Reduced 88.41%
766 $28,000
Q2 2024

Aug 07, 2024

BUY
$24.69 - $40.12 $74,119 - $120,440
3,002 Added 83.18%
6,611 $202,000
Q1 2024

May 07, 2024

SELL
$24.15 - $31.95 $25,961 - $34,346
-1,075 Reduced 22.95%
3,609 $104,000
Q4 2023

Feb 02, 2024

BUY
$18.07 - $29.37 $60,317 - $98,037
3,338 Added 247.99%
4,684 $129,000
Q3 2023

Nov 09, 2023

SELL
$22.41 - $41.99 $16,807 - $31,492
-750 Reduced 35.78%
1,346 $30,000
Q2 2023

Aug 03, 2023

BUY
$40.4 - $59.1 $84,678 - $123,873
2,096 New
2,096 $85,000

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $2.81B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.